SIHUAN PHARM

SIHUAN PHARM logo
🇨🇳China
Ownership
Public
Established
2010-10-06
Employees
2.6K
Market Cap
-
Website
http://www.sihuanpharm.com
Introduction

Sihuan Pharmaceutical Holding Group Co., Ltd. (“Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries is the “Group”) (stock code: 00460.HK) was founded in 2001 and listed on the main board of the Hong Kong Stock Exchange Limited in 2010. It is an international medical, aesthetic and biopharmaceutical enterprise with an independent and lead...

Clinical Trials
Related News

Food Effect Study of Anaprazole in Healthy Chinese Subjects

Phase 1
Completed
Conditions
Healthy Male Volunteers
Interventions
Drug: Anaprazole
First Posted Date
2020-07-09
Last Posted Date
2020-07-09
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
14
Registration Number
NCT04463173

Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

First Posted Date
2020-06-23
Last Posted Date
2020-06-23
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
32
Registration Number
NCT04444011

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects

Phase 1
Completed
Conditions
Healthy Subject
Interventions
Drug: Fadanafil
Drug: Placebo
First Posted Date
2020-03-18
Last Posted Date
2020-03-18
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
66
Registration Number
NCT04312568
Locations
🇨🇳

Haiyan Li, Beijing, Beijing, China

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

First Posted Date
2020-01-02
Last Posted Date
2020-01-02
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
448
Registration Number
NCT04215653

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects

First Posted Date
2019-12-16
Last Posted Date
2019-12-16
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
20
Registration Number
NCT04200261
Locations
🇨🇳

Peking university first hospital, Peking, Beijing, China

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

First Posted Date
2019-02-22
Last Posted Date
2020-07-16
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
390
Registration Number
NCT03851432
Locations
🇨🇳

Linong Ji, Beijing, Beijing, China

Janagliflozin Treat T2DM Monotherapy

First Posted Date
2019-01-22
Last Posted Date
2020-07-16
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
442
Registration Number
NCT03811548
Locations
🇨🇳

Linong Ji, Beijing, Beijing, China

Single-dose PK Study of Benapenem In Healthy Subjects

Phase 1
Completed
Conditions
Healthy Subject
Interventions
Drug: Placebo
Drug: Benapenem
First Posted Date
2018-07-17
Last Posted Date
2018-07-17
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
98
Registration Number
NCT03588156

Benapenem PK Phase Ib Multiple-dose Study

Phase 1
Completed
Conditions
Health, Subjective
Interventions
Drug: Banapenem
First Posted Date
2018-07-06
Last Posted Date
2018-07-06
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
12
Registration Number
NCT03578588

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects

Phase 1
Completed
Conditions
Healthy Subject
Interventions
Drug: Banapenem
First Posted Date
2018-06-27
Last Posted Date
2018-06-27
Lead Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Target Recruit Count
36
Registration Number
NCT03570970
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy